On this page Jump to a section
- Key facts
- Testosterone and erectile dysfunction: desire versus firmness
- Symptoms to bring to your appointment
- How low testosterone is diagnosed
- Testosterone therapy: what FDA approval does—and does not—cover
- What each path includes
- When PDE5 treatment alone may fit
- Do OTC testosterone boosters help erections?
- Safety checks before ED medication
- If ED is the problem you want treated now
- Mendoxa plans and prices
- FAQ
- How we wrote this
- Sources and references
Key facts at a glance
- Testing
- Two early-morning total testosterone measurements; below 300 ng/dL plus symptoms/signs supports the AUA diagnosisNIH-hosted paper summarizing AUA criteria
- Hormone treatment
- Testosterone is approved for deficiency associated with a medical condition, not ED itselfFDA: testosterone labeling update
- ED tablets
- Sildenafil requires sexual stimulationViagra (sildenafil) label · DailyMed
- Compounded status
- The Mendoxa compounded tablet is not FDA-approvedFDA compounding Q&A
Testosterone and erectile dysfunction: desire versus firmness
Sex drive is wanting sex; erection difficulty is trouble getting or keeping sufficient firmness. Low testosterone can affect both, but erections also depend on the brain, nerves and blood vessels (MedlinePlus).
Blood flow belongs in the discussion: NIDDK lists heart and blood vessel disease, diabetes, nerve disorders and hormone problems among causes of ED. A testosterone result addresses only part of that assessment.
For the bigger picture, see our erectile dysfunction guide and ED and diabetes.
Symptoms to bring to your appointment
Use this checklist to describe changes, not to diagnose yourself. A NIH-hosted clinical paper summarizing AUA guidance lists low desire, reduced energy, mood changes and muscle loss among possible low-T symptoms; diagnosis also needs low blood levels.
- Has your interest in sex dropped?
- Is the problem getting firm, staying firm, or both?
- Have morning or nighttime erections changed?
- Have energy, mood or strength changed too?
These questions help organize the sexual history and symptom review described by NIDDK. For morning-erection changes, read no morning wood; the pattern is useful context, not a testosterone test.
How low testosterone is diagnosed
The AUA approach uses a total testosterone cutoff below 300 ng/dL, two early-morning measurements and compatible symptoms or signs, as described in this NIH-hosted clinical paper. One result or a checklist alone does not complete that process.
The AndroGel (testosterone) label separately requires morning measurements on at least two days, both below the normal range, before treatment; it does not supply the AUA 300 ng/dL cutoff.
Bring the actual results and collection times to your clinician. Also bring your medicines, supplements, symptom timeline and prior ED treatments: NIDDK describes history, examination and selected tests as parts of an ED assessment.
Testosterone therapy: what FDA approval does—and does not—cover
Testosterone therapy is not an FDA-approved ED treatment: FDA’s testosterone communication limits approval to low or absent testosterone associated with a medical condition. That approval limit does not mean symptoms can never improve; it means ED alone is not the approved indication.
| Question | What the source establishes | What to discuss |
|---|---|---|
| Approved use | Replacement for primary or hypogonadotropic hypogonadism (AndroGel (testosterone) label) | Whether a hormone deficiency has been established |
| Age-related low T | Safety and efficacy for age-related hypogonadism are not established (AndroGel (testosterone) label) | The underlying diagnosis |
| Blood pressure | Testosterone gel can increase blood pressure; not recommended with uncontrolled hypertension (AndroGel (testosterone) label) | Blood pressure monitoring |
| Gel transfer | Boxed warning: secondary testosterone exposure in children (AndroGel (testosterone) label) | Application and contact precautions |
| Other monitoring | Polycythemia and venous blood clots are label cautions (AndroGel (testosterone) label) | Which checks and follow-up your prescription requires |
Sources: AndroGel (testosterone) label; FDA testosterone labeling update. Accessed Oct 21, 2026.
On February 28, 2025, FDA updated testosterone labeling to remove boxed-warning language about increased adverse cardiovascular outcomes while requiring blood pressure warnings and retaining the age-related limitation. Do not read the removal as an all-clear.
What each path includes
Take two questions to the visit: “What is causing the change?” and “What care fits my erection problem?” The paths below organize that conversation; they are not a self-treatment algorithm.
| Path | Question it addresses | What it includes | Boundary |
|---|---|---|---|
| ED assessment | Getting or keeping erections | History, medicine review, examination and tests as indicated (NIDDK) | A normal hormone result does not finish the ED assessment |
| Hormone workup | Possible low testosterone | Symptoms/signs plus two early-morning blood measurements (AUA criteria summarized on NIH) | Hormone treatment requires its own diagnosis |
| Standalone ED prescription | Whether an ED medicine is suitable | Sildenafil or tadalafil if appropriate (Viagra (sildenafil) label; Cialis (tadalafil) label) | Both require sexual stimulation |
| Mendoxa 3-in-1 visit | Whether the compounded tablet fits | Online review by Independent licensed providers; Prescription required | Mendoxa does not offer testosterone; compounded drugs are not FDA-approved |
Sources: NIDDK diagnosis; NIH-hosted AUA criteria summary; Viagra (sildenafil) label; Cialis (tadalafil) label; FDA compounding Q&A; Mendoxa product information in the ED intake. Accessed Oct 21, 2026.
Ask your doctor whether hormone testing and ED care should proceed together. Compare ED medication options and read can ED be reversed? for questions about underlying causes.
Could Mendoxa ED care fit you?
Online ED visit · Prescription required · Independent licensed providers · Not available in California
When PDE5 treatment alone may fit
When erection firmness is the problem, a clinician may consider an ED prescription after assessing the cause and safety. Viagra (sildenafil) label and Cialis (tadalafil) label list ED as an indication and require sexual stimulation; neither promises success for every person with low T.
Low testosterone is not, by itself, proof that an ED tablet will fail. If desire has also changed or treatment has disappointed you, bring both issues back to the clinician instead of assuming you need testosterone. The Viagra (sildenafil) label calls for assessment of underlying causes.
For practical comparisons, see sildenafil versus tadalafil.
Do OTC testosterone boosters help erections?
Evidence is limited and depends on the ingredient. NIH ODS reports that a trial of Tribulus terrestris did not raise testosterone or luteinizing hormone; NIH NCCIH describes mixed ED findings across trials. Neither finding establishes that an OTC booster will treat your ED.
The FDA warning about testosterone-related hormone products also describes some bodybuilding products containing hidden steroids or steroid-like substances. Use testing and a clinician discussion rather than a marketing claim to decide your next step.
Safety checks before ED medication
- Sildenafil and tadalafil are contraindicated with organic nitrates or riociguat (Viagra (sildenafil) label; Cialis (tadalafil) label).
- An erection lasting more than 4 hours needs immediate medical care (Viagra (sildenafil) label; Cialis (tadalafil) label).
- Stop and seek care for sudden vision loss or sudden decrease or loss of hearing (Viagra (sildenafil) label; Cialis (tadalafil) label).
- Common adverse effects include headache and flushing with sildenafil, and headache, indigestion and back pain with tadalafil (Viagra (sildenafil) label; Cialis (tadalafil) label).
- The APOKYN (apomorphine) label contraindicates use with 5HT3 antagonists such as ondansetron and warns about nausea and fainting.
Give the prescriber your full medicine list. See ED medication and nitrates for more detail.
If ED is the problem you want treated now
Start with the Mendoxa 3-in-1 visit to ask whether its compounded rapid-dissolve tablet fits your ED care. Independent licensed providers assess suitability; Prescription required. Mendoxa does not offer testosterone.
The tablet combines sildenafil, tadalafil and apomorphine; it is not FDA-approved. Ingredient references are the Viagra (sildenafil) label, Cialis (tadalafil) label and APOKYN (apomorphine) label; APOKYN is an injectable Parkinson’s treatment, and its label is not approval of this ED combination.
Bring what you have tried, your current medicines and any hormone results. Explore Mendoxa ED care, the combination ED tablet or the Mendoxa home page. Quantities and costs appear once in the table below.
Mendoxa ED plans and prices
The Mendoxa ED tablet is a compounded rapid-dissolve tablet with sildenafil (the active ingredient in Viagra), tadalafil (the active ingredient in Cialis) and apomorphine (APOKYN label). It dissolves under the tongue. A licensed clinician decides if it fits you and selects the strength. Compounded medicines are not FDA-approved.
| Tablets per month | 1-month total | Per tablet (1 month) | 3-month total | Per tablet (3 months) |
|---|---|---|---|---|
| 6 tablets / month | $129 | $21.50 | $329 | $18.28 |
| 10 tablets / month | $149 | $14.90 | $379 | $12.63 |
| 20 tablets / month | $179 | $8.95 | $449 | $7.48 |
The 3-month total covers three months at the monthly tablet quantity shown.
If prescribed · Cancel anytime · Available in 49 states (not California). Prices from the Mendoxa intake at try.mendoxa.co/f/ed on Oct 21, 2026. The intake always shows the current price.
FAQ
Can a man with low testosterone still get an erection?
Low testosterone can make erections harder and reduce desire, but an ED symptom alone does not establish your hormone level (MedlinePlus). Testing and a symptom review are needed to assess low T (NIH-hosted AUA criteria summary).
Will Viagra work if I have low testosterone?
It may be an option after assessment, but the Viagra (sildenafil) label does not predict an individual response from testosterone status. Sildenafil requires sexual stimulation and is contraindicated with nitrates; low desire deserves a separate discussion with your clinician (Viagra (sildenafil) label).
What if testosterone is normal but I still have ED?
Return for an ED assessment rather than assuming the hormone result settles the cause. NIDDK lists blood vessel disease, diabetes, nerve problems and mental health issues among other causes; NIDDK’s diagnostic guide describes the broader evaluation.
Does no morning wood mean I have low T?
A change is worth mentioning, but it does not measure testosterone. NIDDK describes nighttime erection testing as a way to investigate physical causes; low-T assessment instead uses blood tests and symptoms (NIH-hosted AUA criteria summary).
Will testosterone therapy fix my ED?
An improvement cannot be promised from a low test result alone. FDA’s testosterone update limits approved use to deficiency associated with a medical condition; ED is not an indication on the AndroGel (testosterone) label. Your clinician should assess other ED causes too (NIDDK).
Are testosterone boosters a substitute for prescription ED care?
Evidence is limited: NIH NCCIH describes mixed trial findings for Tribulus and ED. Mendoxa does not offer testosterone; its ED visit is for assessing a compounded tablet, not FDA-approved, with Independent licensed providers. Prescription required.
Ready to see if the Mendoxa ED tablet fits you?
From $129/month if prescribed · Cancel anytime · Available in 49 states (not California)
How we wrote this
Written by the Mendoxa editorial team · Sources: DailyMed/FDA. Medical facts on this page come from the FDA-approved labels on DailyMed and Drugs@FDA; each drug name links to its label. We checked the linked sources on Oct 21, 2026, separating FDA-approved indications from possible symptom benefits and from compounded products. The AUA criteria are corroborated by the introduction of a 2026 NIH-hosted clinical paper; direct access to the AUA guideline was blocked during this update. Forum questions inform FAQ topics, never medical answers.
Updated Oct 21, 2026. This page is general information, not medical advice. A licensed clinician decides what fits you.
References
- DailyMed: VIAGRA (sildenafil citrate) tablet, film coated, label revised 12/2017. Accessed Oct 21, 2026.
- DailyMed: CIALIS (tadalafil) tablet, film coated, label revised 3/2026. Accessed Oct 21, 2026.
- DailyMed: APOKYN (apomorphine hydrochloride) injection, label revised 6/2022. Accessed Oct 21, 2026.
- FDA (Drugs@FDA): VIAGRA (sildenafil) prescribing information, NDA 020895. Accessed Oct 21, 2026.
- FDA (Drugs@FDA): CIALIS (tadalafil) prescribing information, NDA 021368. Accessed Oct 21, 2026.
- FDA: Compounding and the FDA, questions and answers. Accessed Oct 21, 2026.
- DailyMed: AndroGel (testosterone) label. Accessed Oct 21, 2026.
- FDA: testosterone labeling changes, February 28, 2025. Accessed Oct 21, 2026.
- NIDDK: symptoms and causes of ED. Accessed Oct 21, 2026.
- NIDDK: diagnosis of ED. Accessed Oct 21, 2026.
- MedlinePlus: erection problems. Accessed Oct 21, 2026.
- NIH-hosted clinical paper: AUA criteria in the introduction. Accessed Oct 21, 2026.
- NIH ODS: exercise and athletic performance supplements. Accessed Oct 21, 2026.
- NIH NCCIH: sexual enhancement supplement evidence. Accessed Oct 21, 2026.
- FDA: bodybuilding and hormone-product cautions. Accessed Oct 21, 2026.
- Mendoxa ED care (product, format, max 1 dose per 24 hours). Accessed Oct 21, 2026.
- Mendoxa ED intake: plan prices (term_options). Accessed Oct 21, 2026.
About Mendoxa
Mendoxa (mendoxa.co) is a US telehealth brand. Independent licensed providers (licensed clinicians in the LocumTele network) review each online visit, and prescriptions are filled by Rush Pharmacy, a licensed US pharmacy. Available in 49 states (not California).
- Prescription required. A licensed clinician reviews every visit and can say no. A prescription is not automatic.
- A compounded medicine is not an FDA-approved finished product (FDA compounding Q&A).
- Plans: 1 month or 3 months, from $129. If prescribed · Cancel anytime · Available in 49 states (not California).
Compounded medication prescribed only if a licensed U.S. clinician decides it is appropriate. Not FDA-approved as a finished product. Not available in California. This site is not for emergencies. Call 911 if you need urgent care.